Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Feb 3:17:291-296.
doi: 10.2147/NDT.S298005. eCollection 2021.

Cariprazine in Three Acute Patients with Schizophrenia: A Real-World Experience

Jose M Montes  1 , Paloma Montes  2 , Daniel Hernández-Huerta  3
Affiliations
Case Reports

Cariprazine in Three Acute Patients with Schizophrenia: A Real-World Experience

Jose M Montes et al. Neuropsychiatr Dis Treat. .

Abstract

There are still some unmet needs in the treatment of schizophrenia like the persistence of negative symptoms. Cariprazine is a new-generation antipsychotic with partial agonism of the dopamine receptors, distinct from other antipsychotics by its 10 times greater affinity for D3 receptors. This mechanism of action could be especially favorable on patients with predominant negative symptoms. This report is showing three clinical cases of acute schizophrenia exacerbation that required hospitalization and were successfully treated with cariprazine. All of them had predominant positive symptoms and two of them had substance use. Efficacy of cariprazine was also crucial on negative and cognitive symptoms with excellent tolerability.

Keywords: antipsychotics; cariprazine; case report; negative symptoms; schizophrenia.

PubMed Disclaimer

Conflict of interest statement

Dr Montes has received grants from and served as consultant, advisor, or CME speaker for Almirall, Angelini, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Ferrer, GlaxoSmithKline, ISCIII, Janssen-Cilag, Lundbeck, Neuraxpharm, Otsuka, Pfizer, Qualigen, Recordati, Sanofi-Aventis, Servier, and the Spanish Ministry of Science and Innovation (CIBERSAM). Dr Daniel Hernández-Huerta reports personal fees and non-financial support from Janssen, Casen Recordati, Otsuka, Lundbeck, and Angelini, outside the submitted work. The authors report no other conflicts of interest in this work.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Berges A. Schizophrenia In: Ferri FF, editor. Ferri’s Clinical Advisor 2021. Elsevier; 2021:1234.e6–1234.e8.
    1. Rice DP. The economic impact of schizophrenia. J Clin Psychiatry. 1999;60:4–6. - PubMed
    1. Mangalore R, Knapp M. Cost of schizophrenia in England. Ment Health Policy Econ. 2007;10:23–41. - PubMed
    1. Freudenreich O, Brown HE, Holt DJ, et al. Psychosis and Schizophrenia In: Stern TA, Fava M, Wilens TE, Rosenbaum JF, editors. Massachusetts General Hospital Comprehensive Clinical Psychiatry, 2nd NY: Elsevier; 2018:307–323.
    1. Andreasen NC, Arndt S, Alliger R, et al. Symptoms of Schizophrenia: methods, meanings, and mechanisms. Arch Gen Psychiatry. 1995;52(5):341–351. doi:10.1001/archpsyc.1995.03950170015003 - DOI - PubMed

Publication types

LinkOut - more resources